| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.44 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.43 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.36 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.06 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.06 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-05 |